Shilpa Medicare Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
295.00
122.00
54.00
-38.00
102.00
195.00
Adjustment
142.00
195.00
221.00
147.00
109.00
5.00
Changes In working Capital
-35.00
-138.00
-97.00
102.00
-71.00
-106.00
Cash Flow after changes in Working Capital
402.00
179.00
177.00
212.00
139.00
94.00
Cash Flow from Operating Activities
342.00
132.00
136.00
179.00
105.00
46.00
Cash Flow from Investing Activities
-339.00
-198.00
-170.00
-232.00
-285.00
-404.00
Cash Flow from Financing Activities
13.00
62.00
46.00
45.00
82.00
436.00
Net Cash Inflow / Outflow
16.00
-3.00
12.00
-6.00
-97.00
79.00
Opening Cash & Cash Equivalents
28.00
31.00
19.00
25.00
122.00
44.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
45.00
28.00
31.00
19.00
25.00
123.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shilpa Medicare
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
295.31
-67.76
362.00
535.82%
Adjustment
142.45
426.8
-284.00
-66.62%
Changes In working Capital
-35.17
-419.89
384.00
91.62%
Cash Flow after changes in Working Capital
402.59
-60.84
462.00
761.72%
Cash Flow from Operating Activities
342.18
-67.85
409.00
604.32%
Cash Flow from Investing Activities
-339.19
-201.06
-138.00
-68.70%
Cash Flow from Financing Activities
13.62
412.01
-399.00
-96.69%
Net Cash Inflow / Outflow
16.61
143.1
-127.00
-88.39%
Opening Cash & Cash Equivalents
28.57
22.26
6.00
28.35%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
45.18
165.36
-120.00
-72.68%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 158.70% vs -3.22% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
342.18
132.27
158.70%






